Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
about
Sequencing and analysis of a South Asian-Indian personal genomeDNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart diseaseParaoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicityAssociation between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyGenome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritisIncreased influence of genetic variation on PON1 activity in neonates.Neurologic function among termiticide applicators exposed to chlorpyrifosGenetics of oxidative stress in obesityNo association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese populationPolymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphatesParaoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetesParaoxonase 1 polymorphisms within a Mississippi USA population as possible biomarkers of enzyme activities associated with disease susceptibilityParaoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteriaEffects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.Paraoxonase 1 activities and polymorphisms in autism spectrum disordersPON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifosParaoxonase 1 and homocysteine metabolism.Paraoxonases function as unique protectors against cardiovascular diseases and diabetes: Updated experimental and clinical data.The role of phosphotriesterases in the detoxication of organophosphorus compounds.Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study.Paraoxonase genes and disease.Alzheimer's Disease and Paraoxonase 1 (PON1) Gene Polymorphisms.Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue.Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL.Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degenerationParaoxonase1 genetic polymorphisms in a mixed ancestry African populationParaoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitusParaoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.Paraoxonase 1, agricultural organophosphate exposure, and Parkinson diseaseRelationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot studyAssociation between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.Genetic factors of age-related macular degeneration.Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.Paraoxonase-1 55 LL Genotype Is Associated with No ST-Elevation Myocardial Infarction and with High Levels of Myoglobin.Genetics of diabetic retinopathy.Molecular Dynamics Approach in the Comparison of Wild-Type and Mutant Paraoxonase-1 Apoenzyme Form.Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model.Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic Markers.Genes, ageing and longevity in humans: problems, advantages and perspectives.Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes.
P2860
Q21266697-ACEB05F7-C6D8-44D5-B540-6D2FAB07047AQ24538662-8C90F66E-E10B-4716-A991-1E3946CE120FQ24602455-78E1AD7D-CCCE-4650-8FFF-591E03BE6CBDQ24615705-A3C32B45-7CA7-403A-85EF-1BBBC3BA9EE2Q24647387-F2982061-4DD6-4E54-BA8D-D1254651D903Q24815868-3629BC1D-1490-44E8-9522-8AFA878DCACAQ26343705-1E401214-C942-492D-8DEC-32D2FF6A71E9Q27001710-4758A35C-1515-4E45-BC45-BD2D8E09E351Q28139302-BEA4C9C5-9C5D-444E-A2C4-E49AA5AEB75DQ28184693-149F4452-2BA9-4C2F-8B05-68EF67D34C43Q28210667-B1C28DD2-5425-452B-8639-C91DB29DA099Q28243983-A39EEB2E-EC44-4457-9A06-9E9A9A57A419Q28302221-94FA11CE-A448-4454-B510-2FDD3F1D228AQ28364175-28CA3018-59E9-4226-9179-9B8CC24731AAQ28390802-8EEDC1B1-FC7A-4442-B986-0478E5926002Q28391665-8719C17A-3C02-49AC-ADB6-3DE3FB89833DQ30417352-C2C7AB5F-7595-43E1-B2A9-6DEE8FA6EEDCQ30829280-14BF1273-7675-4842-A7DF-BC1FC5226EDDQ33538521-73EC7511-B5EC-42DB-957E-3E418E42517BQ33645551-98339845-481A-42D3-93FA-BB5517F4ABBFQ33708692-24C09CD3-E60A-4B0C-A516-C443CC2A94DBQ33826649-C5A2A228-C52B-4F75-BDCC-2A20D9C783BBQ33902049-DE6E0502-89B3-4AAE-BAAE-9E1074CAEFE0Q34377359-EFBFFC1B-3406-4749-8D51-5231A320825EQ34518470-98C5BB3E-9705-4C41-9E73-C74BBD48BFEAQ34590668-6869A609-B84D-4CFC-B1D1-5BB9F52EF111Q34788675-29FB0077-1957-4868-8866-B3DF4DAF0CBAQ35041945-41690DBF-D5CF-46FC-B046-F0403ADE5C4DQ35053217-59D4B166-085D-4B09-A0FB-EAEE6A78406BQ35401516-984445AA-42DD-4E4D-B598-797D12AD565DQ35737661-BF2D6872-19AA-411E-B870-B746598CC030Q35749765-C6BD717A-D492-485C-A4DB-AC12FB4DEDEAQ35827704-1BEB7FF4-5429-465A-B2DC-1DDE422CD2E3Q35875743-6C0330C5-C2F6-4E5E-8A17-ACB76B57DFB6Q35919740-70D2941F-20D9-48EC-B0B5-22C473A78C9EQ36065303-5126D30D-AD89-40C9-940B-149C76E64AF6Q36494309-02C64BE8-A797-4D93-9ADD-5976C86345B7Q36530464-4FBFA239-CFB0-4612-9935-707E279DB225Q36647435-9D775892-08A1-4A09-A4E9-CEE64F0F568EQ36807458-42751926-D783-401A-8413-3BFEBF2133F0
P2860
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Paraoxonase polymorphism Met-L ...... ovascular disease in diabetes.
@en
Paraoxonase polymorphism Met-L ...... ovascular disease in diabetes.
@nl
type
label
Paraoxonase polymorphism Met-L ...... ovascular disease in diabetes.
@en
Paraoxonase polymorphism Met-L ...... ovascular disease in diabetes.
@nl
prefLabel
Paraoxonase polymorphism Met-L ...... ovascular disease in diabetes.
@en
Paraoxonase polymorphism Met-L ...... ovascular disease in diabetes.
@nl
P2093
P2860
P356
P1476
Paraoxonase polymorphism Met-L ...... ovascular disease in diabetes.
@en
P2093
P2860
P356
10.1172/JCI119134
P407
P577
1997-01-01T00:00:00Z